Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Featured

June
26
2026
June 26, 2026

Turning ECG Data into Actionable Insight with AI

For decades, the ECG has been a fundamental yet relatively limited diagnostic tool in cardiovascular medicine. However, AI-enabled technologies are shifting this paradigm by extracting layers of hidden biological signals…
February
01
2026
February 01, 2026

Anumana Makes Educated Inferences in Heart Failure

Anumana was founded in 2021 as the culmination of a joint effort between the Mayo Clinic and nference, an early entrant to the field of machine learning for cardiology-focused clinical…
November
26
2025
November 26, 2025

Supporting Predictive Analytics to Improve Clinical Decision Making and Patient Outcomes

As we strive to improve clinical decison making and patient outcomes – predictive analytics are a wonderful tool to help us in that goal. But you can’t just decide to throw predictive analytics into…
April
22
2025
April 22, 2025

Cardiology’s AI Moment: Anumana’s Top Insights from ACC.25

#TeamAnumana wrapped up three incredible days of exploring cardiovascular science in the Windy City at the American College of Cardiology’s Annual Scientific Session. ACC.25 brought together thousands of cardiologists, investigators,…